Remedi Non-Registered Executive Jo Seong-ho Acquires 940 Common Shares Through New Listing, Reports 0.01% Stake

Remedi non-registered executive Jo Seong-ho acquired 940 common shares through a new listing on July 13, 2026, resulting in a 0.01% stake.
This is a one-time equity change from the company's listing process, with no dilution risk for existing shareholders.
The reporter serves as managing director of the company, maintaining close ties, and this filing is a routine insider ownership disclosure due to the new listing.
[AI Summary]This report discloses insider equity changes from a new listing, with no impact on the company's capital structure or funding purpose. Thus, dilution or stock price effects on existing shareholders are limited, and investment risk is low.